Immuneering (IMRX) Shares Issued (2020 - 2022)

Immuneering's Shares Issued history runs 3 years deep, the most recent figure standing at $1.8 million for Q4 2022.

• On a quarterly basis, Shares Issued fell 35.42% year-over-year to $1.8 million in Q4 2022; TTM through Dec 2022 was $1.8 million, a 35.42% decrease from a year earlier, with the FY2022 full-year figure at $1.8 million, down 35.42% from the prior year.
• Shares Issued slipped to $1.8 million in Q4 2022 per IMRX's latest filing, from $3.6 million in the prior quarter.
• Across five years, Shares Issued topped out at $3.7 million in Q1 2022 and bottomed at $1.1 million in Q2 2021.
• The 3-year median for Shares Issued is $2.3 million (2021), against an average of $2.4 million.
• Across the five-year window, Shares Issued jumped 58.75% in 2021 and slumped 35.42% in 2022, its largest moves.
• Year by year, Shares Issued stood at $1.8 million in 2020, then jumped by 58.75% to $2.9 million in 2021, then slumped by 35.42% to $1.8 million in 2022.
• Per Business Quant, the three latest IMRX Shares Issued figures stand at $1.8 million (Q4 2022), $3.6 million (Q3 2022), and $1.5 million (Q2 2022).